Edmonton-based biotech 48Hour Discovery is invited to travel to Pangyo Technoo Valley, the Korean version of the Silicon Valley,...

A University of Alberta spinoff company is adding their cutting-edge technology to the search for antiviral compounds to treat...

48Hour Discovery Inc. announced today that it has initiated drug discovery projects for therapeutic targets related to COVID-19. 48Hour Discovery Inc....

New technology platform would deliver orally available small molecule therapeutics for a wide range of targets EDMONTON, ALBERTA (April 18,...

Collaboration receives $300,000 CAD grant to further develop and commercialize TumorGenesis oncology discovery technologies MINNEAPOLIS, April 16, 2019 (GLOBE NEWSWIRE)...

EDMONTON, ALBERTA (April 15, 2019) – 48Hour Discovery INC., a biotechnology company focused on the discovery of peptide-derived small molecule therapeutics,...

EDMONTON, ALBERTA (March 11, 2019) – 48Hour Discovery Inc. announced the appointment of David Alton as the Director of Business...

EDMONTON (April 17 2018)–48Hour Discovery Inc. (48HD) is pleased to announce a sponsorship with the Canadian Glycomics Network (GlycoNet)...

Join us for an exclusive tour of our molecular discovery platform. This half day workshop will take you through our exciting...

Edmonton-based start-up to develop personalized cancer therapy models: EDMONTON (March 29, 2018)–48Hour Discovery Inc. (48HD) announced today that they...